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E-mail address: song@embl-hamburg.de (Y.-H. SonIn prokaryotes, operon encoded proteins often form protein–protein complexes. Here, we show that
the native structure of operons can be used to efﬁciently overexpress protein complexes. This study
focuses on operons from mycobacteria and the use of Mycobacterium smegmatis as an expression
host. We demonstrate robust and correct stoichiometric expression of dimers to higher oligomers.
The expression efﬁcacy was found to be largely independent of the intergenic distances. The strategy
was successfully extended to express mycobacterial protein complexes in Escherichia coli, showing
that the operon structure of gram-positive bacteria is also functional in gram-negative bacteria. The
presented strategy could become a general tool for the expression of large quantities of pure pro-
karyotic protein complexes for biochemical and structural studies.
Structured summary:
MINT-7542207: ESAT-6 (uniprotkb:Q50206) and CFP-10 (uniprotkb:O33084) bind (MI:0407) by blue
native page (MI:0276)
MINT-7542534: ESAT-6 (uniprotkb:P0A564) and CFP-10 (uniprotkb:P0A566) bind (MI:0407) byX-ray crys-
tallography (MI:0114)
MINT-7542187: CFP-10 (uniprotkb:P0A566) and ESAT-6 (uniprotkb:P0A564) bind (MI:0407) by blue native
page (MI:0276)
MINT-7542652: CFP-10 (uniprotkb:P0A566) and ESAT-6 (uniprotkb:P0A564) bind (MI:0407) by molecular
sieving (MI:0071)
MINT-7542474, MINT-7542303: CFP-10 (uniprotkb:P0A566) physically interacts (MI:0915) with ESAT-6
(uniprotkb:P0A564) by pull down (MI:0096)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The structural and functional characterization of multi-compo-
nent protein complexes is a major area of study in the ﬁeld of
systems biology. In the past decade of the post genomic era, sev-
eral protein interaction networks of diverse organisms have been
reported [1]. These studies have revealed that proteins often do
not function in isolation within cells, but form functional com-
plexes by associating to binding partners. Although it has been
known for a long time that functionally related genes are orga-
nized in operons in prokaryotes and that they are transcribed in
a coordinated manner [2], systematic computational studies for
prediction of operons have only been carried out recently [3].
To study protein complexes at the structural or biochemical level,
generally milligrams of puriﬁed complex are required. Recombi-chemical Societies. Published by E
g).nant technology has been routinely used to produce single pro-
teins using heterologous expression systems. Although several
co-expression strategies are available for both eukaryotic and
prokaryotic hosts, it often remains challenging to obtain large
amounts of native protein complexes with deﬁned stoichiometric
functional compositions [4]. Here we take advantage of the fact
that functionally related genes in prokaryotes are organized in
operons and that they are co-transcriptionally and co-translation-
ally regulated [2,5,6]. Currently about 1110 bacterial genomes
have been sequenced [7]. Systematic computational tools for
the annotation of genes are being developed and several studies
are available for predicting prokaryotic operons [3,5,8]. Studies
aimed at predicting Mycobacterium tuberculosis (M. tuberculosis)
operons have recently suggested that there are more than 1000
operons consisting of two or more open reading frames (ORFs)
[3,9,10]. These data also indicate that more than half of the
4000 ORFs of M. tuberculosis are organized in operons [3,11] (Sup-
plementary Table 1).lsevier B.V. All rights reserved.
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a generic, effective and reliable expression and puriﬁcation method
for protein complexes by exploiting the native operon structures in
M. tuberculosis. Initially we explored whether native operons are
functional in a homologous expression host of the same taxon, in
this case M. smegmatis. As proof of principle, we explored three
paralogous and two orthologous operons of the WXG-100 protein
family. To further demonstrate the applicability of our method,
we extended the study to the operon encoding the proteasome, a
large protein oligomer. Furthermore, we show that the operon
structures of a gram-positive bacterium (M. tuberculosis) are also
recognized heterologously by a gram-negative bacterium (Esche-
richia coli). This study represents a substantial advance in that (i)
it reduces the design of multi-gene expression constructs to a sin-
gle step and (ii) it permits the expression of milligrams of protein
complex in a native and functional state using inducible
promoters.2. Materials and methods
2.1. Construction, expression and puriﬁcation of recombinant protein
complexes
For the construction of the expression vectors, the studied oper-
ons were ampliﬁed from genomic DNA of M. tuberculosis (strain
H37Rv), M. leprae and M. smegmatis (strain mc2 155) using PCR.
The employed expression vectors were pMyNT, a pSD26 derivative,
for over-expression in M. smegmatis [12] and pETM-Z (a kind gift
from Günter Stier) or pETM-11 [13] for over-expression in E. coli.
The primers were designed such that the PCR products could be li-
gated into the expression vectors, which were linearized using the
restriction enzymes, NcoI, BamHI and HindIII, respectively. Primers
are listed in Supplementary Table 2.
All methods relating to protein expression inM. smegmatiswere
carried out following the reported method [12]. In brief, the M.
smegmatismc2 155 competent cells were transformed with the po-
sitive recombinant plasmids using electroporation and plated out
on 7H10 agar plates supplemented with 50 lg/mL hygromycin.
Single colonies were inoculated to express the protein complex
of interest. The culture medium consisted of Middlebrook 7H9
medium supplemented with 0.2% (v/v) glycerol, 0.2 % (w/v) glu-
cose, 0.05% (v/v) tween 80 and 50 lg/mL hygromycin. The cultur-
ing condition was 37 C with a 200 rpm shaking speed. The
protein expression was started at 2.0 OD600nm by adding acetamide
to a ﬁnal concentration of 35 mM.
Expression in E. coli was carried out by following the reported
method [32] using BL21(DE3) Codon Plus RIL strain (Stratagene).
In both expression systems the cells were incubated over night
after induction of protein expression.
The puriﬁcation of the expressed protein complexes was stan-
dardized. The crude extracts were obtained by centrifugation
(30.000 rcf) after sonication of the cells in the extraction buffer,
50 mM Tris–HCl, pH 8.0, 300 mM NaCl and 20 mM imidazol. The
protein complexes were further puriﬁed in three steps. First, His-
afﬁnity chromatography was performed using 50 mM Tris–HCl,
pH 8.0, 300 mM NaCl, 500 mM imidazol as elution buffer. Second,
the His-tag was removed by TEV protease treatment in extraction
buffer supplemented with 10 mM b-mercapto-ethanol, and as the
polishing step size-exclusion chromatography was applied using
the buffer, 50 mM Tris–HCl, pH 8.0, 300 mM NaCl.
2.2. Mass spectrometry analysis
The puriﬁed complexes were identiﬁed by mass spectroscopic
analysis. The samples were prepared according to the manufac-turer’s instruction. In brief, the excised bands from the SDS and na-
tive gels were destained, dehydrated, vacuum dried and incubated
overnight with methylated porcine trypsin (trypsin gold, Prome-
ga). Peptides, as well as full-length complex, were analyzed with
MALDI-TOF using a Voyager-DE-STR mass spectrometer.
2.3. Sample preparation for electron microscopy (EM)
The specimens for electron microscopy were prepared accord-
ing to published methods [14]. In brief, about 1–2 lL proteasome
solution at a concentration of 0.5 lM were applied to a carbon
coated, glow discharged 600-mesh EM grid. The specimens were
negatively contrasted by overlaying with 2% uranyl acetate. The
electron micrographs were recorded on a Philips CM12 microscope
in low dose mode.3. Results
3.1. Native operon structures are recognized by bacteria within the
same taxon
Comparative genomic analyses of M. tuberculosis and the aviru-
lent vaccine strain BCG have revealed 16 Regions of Difference, des-
ignated RD1-RD16, respectively [11,15,16]. Among them, RD1 is
the only region which is present in all virulent strains and absent
in all avirulent ones [17,18]. The potential virulence factors CFP-
10 and ESAT-6 have been studied intensively due to their property
to generate strong T cell immune responses [19]. They are encoded
in an operon that is an integral part of RD1 [20]. CFP-10 and ESAT-6
(Rv3874, Rv3875) form a 1:1 heterodimeric complex [21,22]. The
two proteins are part of a large protein family, which is generally
present among mycobacteria irrespective of their virulence [23].
The genome of M. tuberculosis contains 11 CFP-10/ESAT-6-like
pairs, ﬁve pairs of which are situated within their own gene clus-
ters encoding a type-VII secretion system as in RD1. The NMR
structure of the CFP-10/ESAT-6 complex was determined from pro-
teins that were separately expressed in E. coli and co-refolded, post
puriﬁcation, to produce a heterodimeric complex [21].
Here, we have cloned the entire coding region of the CFP-10/
ESAT-6 operon, including their intergenic base pairs into the
expression vector pMyNT (Fig. 1A), to be used in the homologous
expression host M. smegmatis. The CFP-10/ESAT-6 complex could
be expressed and puriﬁed in an equimolar ratio of the two protein
components (Fig. 2A, lanes 1 and 4). The yield of puriﬁed protein
complex was about 8 mg per litre of cell culture.
We further tested the method for other CFP-10/ESAT-6-like
coding operons, all of which possess different intergenic distances
ranging from 10 to 32 base pairs (Fig. 1B). The sequence identity
between the different paralogs and orthologs is in the range of
15–65%. We were able to successfully express three CFP-10/
ESAT-6 paralogous complexes from M. tuberculosis and the orthol-
ogous complexes fromM. leprae andM. smegmatis (Fig. 4). All pairs
were expressed in equimolar ratios and therefore migrated as sin-
gle bands with native PAGE (polyacrylamide gel electrophoresis)
(Fig. 4B). This conﬁrms that the native operon structures can be
used for homologous recombinant expression of targets consisting
of two ORFs, irrespective of the different intergenic distances and
base pairs.
To generalize and to demonstrate the advantages of our method
in the context of potentially challenging large protein assemblies,
we selected a high molecular weight test system from M. tubercu-
losis, the proteasome complex, for expression. The proteasome is
encoded by an operon containing the ORFs Rv2109c (a-subunit)
and Rv2110c (b-subunit), forming an a7b7b7a7 complex with
a molecular weight of 730 kDa [24]. With our protocol, this
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Fig. 1. Schematic diagram of the cloning strategy of the complex expression vectors using their native operon structures. (A) Key features of the vectors are shown: Top:
pMyNT: vector backbone corresponds to the pSD26 plasmid [12] with twomodiﬁcations: (i) deleting the six initial codons of acetamidase, (ii) inserting a multiple cloning site
(MCS) consisting of restriction endonuclease sites, NcoI, KpnI, BamHI, EcoRI, EcoRV and HindIII. Middle: pETM-11: E. coli expression vector under the control of the T7
promoter. The ﬁrst ORF of the inserted operon is expressed as an afﬁnity His6-tagged protein. Bottom: pETM-Z: E. coli expression vector under the control of the T7 promoter.
The ﬁrst ORF in the operon is expressed as a double tag with an afﬁnity puriﬁcation tag, His6, and a solubilization tag, Z-tag. The second protein is expressed without an
afﬁnity tag. These two E. coli vectors have been used only for Rv3874/Rv3875. We have used the insertion sites NcoI, BamHI and HindIII. RBS stands for the ribosomal binding
site. (B) All cloned native operons in this report are shown schematically and their intergenic distance and nucleotides between the two ORFs are also listed.
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1 L of culture (Fig. 4, lane 7).
3.2. Biophysical and structural biological characterization of the
protein complexes
All protein complexes, expressed and puriﬁed using their native
operon content, were analyzed using circular dichroism spectros-
copy, static light scattering and mass spectrometry. All proteins
of CFP-10/ESAT-6-like complexes show a CD spectrum with high
a-helix content (Supplementary Fig. S2) and form a 1:1 stoichiom-
etric complex (Figs. 2 and 4). The analysis using mass spectrometry250
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Fig. 2. The CFP-10/ESAT-6 complex of M. tuberculosis is recombinantly expressed in a 1:1
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lanes 1 and 4 both represent the equimolar CFP-10/ESAT-6 complex.revealed that all proteins are full-length proteins. The peptide mass
ﬁngerprinting analysis using MALDI-TOF spectrometry showed
that the proteins co-migrate as one band on a native-PAGE and
the band contains the CFP-10/ESAT-6 complex (Fig. 2B, Supple-
mentary Fig. S1). All other protein complexes also co-migrate as
one band on a native-PAGE and form 1:1 stoichiometric
complexes.
To further assess whether the proteins form complexes with
functional conformations we analyzed the selected complexes
using X-ray crystallography and electron microscopy. We were
able to crystallize the CFP-10/ESAT-6 complex of the RD-1 region
and determine its structure (Fig. 3A). It forms a tight, four-helicalZ-
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Fig. 3. Structural biological studies of protein complexes prepared using the recombinant expression methodology reported here. (A) The CFP-10/ESAT-6 complex could be
puriﬁed in sufﬁcient amounts to carry out extensive crystallization screening. Crystals suitable for diffraction studies were obtained. Ribbon representation of X-ray structure
of CFP-10/ESAT-6 showing a four-helical bundle complex (PDB: 3FAV) [31]. (B) Electron micrograph of the proteasome complex showing the complex forming a barrel
structure with 7-fold symmetry. The proteasome complex was puriﬁed using single-step IMAC chromatography.
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proteasome complex was characterized using electron microscopy.
It forms a a7b7b7a7 complex with a barrel-like structure (Fig. 3B).
3.3. Native operon structure of M. tuberculosis, a gram-positive
bacteria, is recognized by the gram-negative bacteria, E. coli
After demonstrating that the native operon structure of myco-
bacterial genomes can be transferred to a homologous recombi-
nant expression system, we wanted to determine if the method
could be generally applied to all prokaryotes, by transferring the
operons into the heterologous E. coli expression system, the most
used expression system. To establish proof of principle we chose
the operon encoding the CFP-10/ESAT-6 protein complex of M.
tuberculosis [23], which we studied extensively in this report, for
expression in E. coli. The entire coding region of the CFP-10/
ESAT-6 operon was cloned into the pETM-Z expression vector.
Effectively we replaced the native promoter with the inducible
T7 promoter, which controls the transcription of the cloned operon
(Fig. 1A, middle and bottom). The expressed complex consists ofdouble-tagged CFP-10 and untagged ESAT-6. The tag consists of
an N-terminal His6-tag and a solubilisation Z-tag, a domain of pro-
tein A originating from Staphylococcus aureus (Fig. 2A, lane 3).
Interestingly, both proteins encoded in the M. tuberculosis operon
are expressed in E. coli, demonstrating that the operon structure
of a gram-positive bacterium (of the phylum Actinobacteria) is rec-
ognized by a gram-negative bacterium (E. coli). However, gel elec-
trophoresis revealed that CFP-10, the upstream gene of the operon
in our construct, was expressed at levels more than 10-fold higher
than ESAT-6 (Fig. 2A, lanes 3 and 6). Recloning the operon into
pETM-11, resulting in the removal of the Z-tag, yielded a similar
skewed expression pattern (Fig. 2A, lanes 2 and 5), showing that
the non-equimolar expression levels are independent of the tag
(Fig. 2A, lanes 2, 3, 5 and 6).
4. Discussion
In summary, we present a generic strategy for the expression of
prokaryotic protein complexes encoded by genes organized in a
single operon structure. We have shown that by maintaining the
C. Poulsen et al. / FEBS Letters 584 (2010) 669–674 673native operon structure in an expression system, it is possible to
produce large amounts of protein complexes assembled in correct
stoichiometry.
One of the aims of this work was to produce protein complexes
fromM. tuberculosis for structural studies. It has been reported that
30–50% of allM. tuberculosis targets expressed in E. coli result in the
formation of inclusion bodies [26], either because of a non-com-
patible expression host or because the expressed single protein
lacks its essential protein complex partner(s). To date, close to
500 structures from about 200 M. tuberculosis ORFs have been
deposited in the Protein Data Bank [27], but only four structures
of protein–protein complexes are available: the proteasome, the
PE25/PPE41 complex, the toxin–antitoxin complex VapBC-5 and
the CFP-10/ESAT-6 complex [24,25,28,29]. These four complexes
were produced using three different methods: by co-expression
in E. coli using a bi-cistronic expression vector with two separate
promoters [24], by the use of a single T7 promoter with an addi-
tional synthetic ribosomal binding site between the ORFs [28,29]
or by the generation and puriﬁcation of individual proteins and
subsequent co-refolding [25]. Although the ﬁrst two complexes
could be co-expressed, the employed methods are cumbersome,
since the ORFs were dissected and handled individually. The meth-
od presented in this paper offers substantial advantages over the
methods currently being employed; e.g., the cloning effort is re-
duced to a single step with no need to manipulate multiple genes.
Due to the maintenance of the functional genetic context, complex
formation will occur co-translationally, and biologically active pro-
tein complexes are formed. To demonstrate further the advantages
of this method we chose the M. tuberculosis proteasome complex
for expression, because (i) the recombinant production of the pro-
teasome complex from M. tuberculosis has been well documented
in the literature [30], and (ii) it is a 28mer complex with a molec-
ular weight of 730 kDa. We were able to complete all the steps
from cloning to the analysis of the proteasome complex using elec-
tron microscopy within nine days. These results demonstrate that
this method is well suited for delivering large amounts of highly-
pure protein complexes that are required for X-ray crystallography
and biochemical studies.
Many prokaryotic genomes have been sequenced and tools are
currently being developed to predict operons and protein–protein
interactions [3]. The methodology presented here opens a new
avenue to explore prokaryotic protein complexes and experimen-
tally validate bioinformatics-based predictions of complex
formation.
We believe this newmethod will become one of the key tools to
exploit the rich and diverse genetic information available at the
molecular level, and will enable the study of a broad range of com-
plex systems, such as enzymatic pathways, secretion machineries
and transcription complexes. This approach is not limited to com-
plexes encoded by a single operon, but could be extended to a mul-
ti-operonic expression construct. It could be used to pursue the
experimental study of a bacterium in a system biology context at
the molecular level. The ready availability of pure protein com-
plexes in milligram quantities has important implications for fun-
damental research, as well as for drug target validation and for
drug discovery targeting human pathogens, such as M. tuberculosis
and M. leprae.
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